Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227441 · ClinicalTrials.gov registry record
Chronic Infections and Inflammation in ME/CFS: An Observational Study
A clinical trial of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07227441 is a study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07227441, a study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
CHIIME is a study of people who have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). People who do not have this condition will also be enrolled. Volunteers will be observed and sampled over time to identify the long-terms biological drivers and impact of their condition. The overall goal is to understand the biological and physiological mechanisms that are driving this condition.
Conditions Studied
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2030-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07227441
The ClinicalTrials.gov registry entry for NCT07227441 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT07227441 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07227441 about?
NCT07227441 is a clinical study titled "Chronic Infections and Inflammation in ME/CFS: An Observational Study". CHIIME is a study of people who have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). People who do not have this condition will also be enrolled. Volunteers will be observed and sampled over time to identify the long-terms biological drivers and impact of their condition. The overall go...
What is the current status of trial NCT07227441?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-01-01. Estimated completion is 2030-09.
What conditions does trial NCT07227441 study?
This clinical trial studies the following conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Who is sponsoring clinical trial NCT07227441?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227441 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.